Table 6 Comparison between CT and PET/CT between 1st and 2nd follow-up cases regarding local recurrence and distant metastasis:
From: Role of 18F FDG PET/CT in evaluation of post-operative ovarian carcinoma
Levels | CT | PET CT | Test of significance |
|---|---|---|---|
Local tumor recurrence | |||
No | 36 (78.3%) | 31 (67.4%) | Fisher test |
Yes | 10 (21.7%) | 9 (19.6%) | 0.282 |
Progression | 0 (0.0) | 2 (4.3%) | |
Regression | 0 (0.0) | 2 (4.3%) | |
Remitted | 0 (0.0) | 1 (2.2%) | |
Stationary | 0 (0.0) | 1 (2.2%) | |
Peritoneal deposits | |||
No | 37 (80.4%) | 11 (23.9%) | Fisher test |
Yes | 6 (13.0%) | 17 (37.0%) | < 0.001* |
De novo | 0 (0.0) | 1 (2.2%) | |
Progressed | 1 (2.2%) | 5 (10.9%) | |
Regressed | 2 (4.3%) | 4 (8.7%) | |
Remitted | 0 (0.0) | 5 (10.9%) | |
Stationary | 0 (0.0) | 3 (6.5%) | |
Suspicious abdominal LNs | |||
Yes | 12 (26.1) | 10 (22.7%) | Fisher test |
No | 34 (73.9) | 23 (52.3%) | 0.0047* |
De novo | 0 (0.0) | 2 (4.5%) | |
Progressed | 0 (0.0) | 1 (2.3%) | |
Regressed | 0 (0.0) | 1 (2.3%) | |
Remitted | 0 (0.0) | 7 (15.9%) | |
Suspicious Pelvic LNs | |||
Yes | 5 (10.9%) | 12 (26.1%) | Fisher test |
No | 40 (87.0%) | 24 (52.2%) | 0.001* |
De novo | 0 (0.0) | 2 (4.3%) | |
Progressed | 0 (0.0) | 1 (2.2%) | |
Regressed | 1 (2.2%) | 1 (2.2%) | |
Remitted | 0 (0.0) | 6 (13.0%) | |
Distant organ Metastasis | |||
Yes | 5 (10.9%) | 7 (15.2%) | Fisher test |
No | 40 (87.0%) | 31 (67.4%) | 0.119 |
De novo | 0 (0.0%) | 4 (8.7%) | |
Progressed | 0 (0.0) | 1 (2.2%) | |
Regressed | 1 (2.2) | 1 (2.2%) | |
Remitted | 0 (0.0) | 1 (2.2%) | |
Stationary | 0 (0.0) | 1 (2.2%) | |
End results | |||
No | 22 (47.8%) | 11 (23.9%) | Chi-square test |
Yes | 24 (52.2%) | 35 (76.1%) | 0.03 |